Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression (original) (raw)
References
Ahonen, M, Baker, AH & Kahari, VM (1998) Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res58: 2310–2315 CASPubMed Google Scholar
Butler, GS, Butler, MJ, Atkinson, SJ, Will, H, Tamura, T, van-Westrum, SS, Crabbe, T, Clements, J, d’Ortho, MP & Murphy, G (1998) The TIMP2 membrane type 1 metalloproteinase ‘receptor’ regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem273: 871–880 ArticleCASPubMed Google Scholar
Chambers, AF & Matrisian, LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst89: 1260–1270 ArticleCASPubMed Google Scholar
Coussens, LM & Werb, Z (1996) Matrix metalloproteinases and the development of cancer. Chem Biol3: 895–904 ArticleCASPubMed Google Scholar
Durko, M, Navab, R, Shibata, HR & Brodt, P (1997) Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochim Biophys Acta1356: 271–280 ArticleCASPubMed Google Scholar
Ferrier, CM, van Geloof, WL, de Witte, HH, Kramer, MD, Ruiter, DJ & van Muijen, GN (1998) Epitopes of components of the plasminogen activation system are re-exposed in formalin-fixed paraffin sections by different retrieval techniques. J Histochem Cytochem46: 469–476 ArticleCASPubMed Google Scholar
Gomez, DE, Alonso, DF, Yoshiji, H & Thorgeirsson, UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol74: 111–122 CASPubMed Google Scholar
Grant, GM, Cobb, JK, Castillo, B & Klebe, RJ (1996) Regulation of matrix metalloproteinases following cellular transformation. J Cell Physiol167: 177–183 ArticleCASPubMed Google Scholar
Heppner, KJ, Matrisian, LM, Jensen, RA & Rodgers, WH (1996) Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol149: 273–282 CASPubMedPubMed Central Google Scholar
Imren, S, Kohn, DB, Shimada, H, Blavier, L & DeClerck, YA (1996) Overexpression of tissue inhibitor of metalloproteinases-2 retroviral-mediated gene transfer in vivo inhibits tumor growth and invasion. Cancer Res56: 2891–2895 CASPubMed Google Scholar
Kanayama, H, Yokota, K, Kurokawa, Y, Murakami, Y, Nishitani, M & Kagawa, S (1998) Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer82: 1359–1366 ArticleCASPubMed Google Scholar
Khokha, R (1994) Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst86: 299–304 ArticleCASPubMed Google Scholar
Khokha, R, Zimmer, MJ, Wilson, SM & Chambers, AF (1992) Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo. Clin Exp Metastasis10: 365–370 ArticleCASPubMed Google Scholar
Lambert, K, Machein, U, Machein, MR, Conca, W, Peter, HH & Volk, B (1998) Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol153: 429–437 Article Google Scholar
MacDougall, JR & Matrisian, LM (1995) Contribution of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev14: 351–362 ArticleCASPubMed Google Scholar
MacDougall, JR, Bani, MR, Lin, Y, Rak, J & Kerbel, RS (1995) The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res55: 4174–4181 CASPubMed Google Scholar
Montgomery, AM, Mueller, BM, Reisfeld, RA, Taylor, SM & DeClerck, YA (1994) Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res54: 5467–5473 CASPubMed Google Scholar
Mueller, BM (1996) Different roles for plasminogen activators and metalloproteinases in melanoma metastasis. Curr Top Microbiol Immunol213: 65–80 CASPubMed Google Scholar
Nagase, H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem378: 151–160 CASPubMed Google Scholar
Nakahara, H, Howard, L, Thompson, EW, Sato, H, Seiki, M, Yeh, Y & Chen, WT (1997) Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA94: 7959–7964 ArticleCASPubMedPubMed Central Google Scholar
Newell, KJ, Witty, JP, Rodgers, WH & Matrisian, LM (1994) Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog10: 199–206 ArticleCASPubMed Google Scholar
Nielsen, BS, Timshel, S, Kjeldsen, L, Sehested, M, Pyke, C, Borregaard, N & Dano, K (1996) 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer65: 57–62 ArticleCASPubMed Google Scholar
Nomura, H, Sato, H, Seiki, M, Mai, M & Okada, Y (1995) Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res55: 3263–3266 CASPubMed Google Scholar
Ray, JM & Stetler Stevenson, WG (1995) Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J14: 908–917 ArticleCASPubMedPubMed Central Google Scholar
Sato, H, Takino, T, Okada, Y, Cao, J, Shinagawa, A, Yamamoto, E & Seiki, M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature370: 61–65 ArticleCASPubMed Google Scholar
Sreenath, T, Matrisian, LM, Stetler, SW, Gattoni, CS & Pozzatti, RO (1992) Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res52: 4942–4947 CASPubMed Google Scholar
Stetler Stevenson, WG, Aznavoorian, S & Liotta, LA (1993) Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol9: 541–573 ArticleCASPubMed Google Scholar
Strongin, AY, Collier, I, Bannikov, G, Marmer, BL, Grant, GA & Goldberg, GI (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J Biol Chem270: 5331–5338 ArticleCASPubMed Google Scholar
Sugiura, Y, Shimada, H, Seeger, RC, Laug, WE & DeClerck, YA (1998) Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res58: 2209–2216 CASPubMed Google Scholar
Tokuraku, M, Sato, H, Murakami, S, Okada, Y, Watanabe, Y & Seiki, M (1995) Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer64: 355–359 ArticleCASPubMed Google Scholar
Vaisanen, A, Tuominen, H, Kallioinen, M & Turpeenniemi Hujanen, T (1996) Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol180: 283–289 ArticleCASPubMed Google Scholar
Vaisanen, A, Kallioinen, M, Taskinen, PJ & Turpeenniemi-Hujanen, T (1998) Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. J Pathol186: 51–58 ArticleCASPubMed Google Scholar
Valente, P, Fassina, G, Melchiori, A, Masiello, L, Cilli, M, Vacca, A, Onisto, M, Santi, L, Stetler Stevenson, WG & Albini, A (1998) TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer75: 246–253 ArticleCASPubMed Google Scholar
van den Oord, JJ, Paemen, L, Opdenakker, G & de Wolf Peeters, C (1997) Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol151: 665–670 CASPubMedPubMed Central Google Scholar
van Muijen, GN, Cornelissen, LM, Jansen, CF, Figdor, CG, Johnson, JP, Brocker, EB & Ruiter, DJ (1991a) Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice. Clin Exp Metastasis9: 259–272 ArticleCASPubMed Google Scholar
van Muijen, GN, Jansen, KF, Cornelissen, IM, Smeets, DF, Beck, JL & Ruiter, DJ (1991b) Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int J Cancer48: 85–91 ArticleCASPubMed Google Scholar
Westphal, JR, van’t Hullenaar, RG, van der Laak, JA, Cornelissen, IM, Schalkwijk, LJ, van Muijen, GN, Wesseling, P, de Wilde, PC, Ruiter, DJ & de Waal, RM (1997) Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. Br J Cancer76: 561–570 ArticleCASPubMedPubMed Central Google Scholar
Wooley, DE & Grafton, CA (1980) Collagenase immunolocalization studies of cutaneous secondary melanomas. Br J Cancer42: 260–265 Article Google Scholar
Yamamoto, M, Mohanam, S, Sawaya, R, Fuller, GN, Seiki, M, Sato, H, Gokaslan, ZL, Liotta, LA, Nicolson, GL & Rao, JS (1996) Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res56: 384–392 CASPubMed Google Scholar
Zucker, S, Drews, M, Conner, C, Foda, HD, DeClerck, YA, Langley, KE, Bahou, WF, Docherty, AJP & Cao, J (1998) Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem273: 1216–1222 ArticleCASPubMed Google Scholar